Western blotting (WB) as in Methods for levels of Oncogenes MET, AKT, mToR1, p70S6K in panel A while expression of growth inhibitory and proapoptotic genes such as CARP-1, cyclin B1, cleaved PARP and caspase-8, and activation (phosphorylation) of pro-apoptotic p38 and JNK1/2 SAPKs was analyzed in panel B. The western blot membranes were subsequently probed with α-tubulin antibodies to assess equal loading. The presence of respective protein is indicated by an arrowhead on the left side of each blot. Approximate location of various molecular weight markers is indicated on the right side of each blot. kDa, kilodalton. (C) The Erlotinib-R subline 4 and Rociletinib-R subline 2 were treated with DMSO (Control) or with noted agents for indicated dose and time. Cell viability was determined by MTT assay. The histogram columns indicate live/viable cells and represent means of two independent experiments; bars, S.E. α, β, p = < 0.05 relative to the respective DMSO-treated controls. Of note is that all the TKI-resistant sublines of Table 1 had elevated levels of p-p38, and p-p65 (not shown). For brevity, (A) shows data from two, TKI-resistant HCC827 and H1975 cells.
4.16 has superior efficacy when used in combination with therapeutics that target MET, Src (B), or EGFR (D). Lysates derived from indicated parental and Erlotinib-resistant NSCLC cells were analyzed by Western blotting (WB) as in Methods for levels and activities (phosphorylation) of Oncogenes MET, AKT, mToR1, p70S6K in (A) while lysates derived from parental and Rociletinib-resistant NSCLC cells were analyzed for expression and activation (phosphorylation) of EGFR in (C). The WB membranes were subsequently probed with α-tubulin antibodies to assess equal loading. The presence of respective protein is indicated by an arrowhead on the left side of each blot. Approximate location of various molecular weight markers is indicated on the right side of each blot. kDa, kilodalton. (B, C) Noted cell lines were either treated with DMSO (Control) or with various compounds for indicated dose and time. Cell viability was determined by MTT assay. The data in the histograms represent means of three independent experiments; bars, S.E. α, β, δ, κ, γ, ρ, p = < 0.05 relative to the respective DMSO-treated controls.
